Xendara Bio ApS

CVR 46601947 · Private limited company (ApS) · Active · Medium risk

Xendara Bio ApS is a Private limited company (ApS), founded on , based in København N. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 1.6% over the next 12 months, which is 1.1 times the average for Danish companies. CEO: Kåre Engkilde.

Bankruptcy risk for Xendara Bio ApS

1.6%
probability of bankruptcy within 12 months
Medium risk

1.1 × the average (1.41%) · higher risk than 79% of active Danish companies

Lowest riskHighest risk

Increases the risk

Published annual reports0 · bankruptcy rate 16.7%1.9×
Age (years)< 1 yrs · bankruptcy rate 12.9%1.5×
Time at current address< 0.5 yrs · bankruptcy rate 12.0%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Time since new CEO< 0.5 yrs · bankruptcy rate 11.6%1.3×
Other companies at the same address100+ · bankruptcy rate 11.5%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×

Reduces the risk

Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×
Registered owners4+ · bankruptcy rate 5.7%0.65×
Has a boardYes · bankruptcy rate 6.0%0.68×
Number of auditors (historical)1 · bankruptcy rate 6.2%0.70×
Moves in the last 2 years0 · bankruptcy rate 7.4%0.84×
Marketing-protectedNo · bankruptcy rate 7.5%0.85×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
46601947
Status
Active
Company type
Private limited company (ApS)
Founded
(0 years)
Address
Ole Maaløes Vej 3
2200 København N
Municipality
København
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 20k
Auditor
AIDER Godkendt Revisionsaktieselskab
Audit opted out
No

Warning signs

Annual reports filed late0 of 0
Missing annual reportNo
Negative equity–
Equity ratio–
Current ratio–
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address167
Going-concern uncertaintyNo

Management, owners and auditor

RoleNameFromTo
CEOKåre EngkildeCurrent
BoardSten VerlandCurrent
BoardSine HadrupCurrent
BoardKåre EngkildeCurrent
Owner (15%)Hadrup BioMed Holding ApSCurrent
Owner (33%)Elsevej Invest ApSCurrent
Owner (15%)Yi Sun Holding ApSCurrent
Owner (5%)Hófí Holdings ApSCurrent
Owner (15%)MSF Forvaltning ABCurrent
Owner (5%)Erik Ekengard ABCurrent
Owner (100%)Elsevej Invest ApS
AuditorAIDER Godkendt RevisionsaktieselskabCurrent
FounderElsevej Invest ApSCurrent

The CEOs' other companies

Kåre Engkilde – 1 other companies

Address history (0 moves)

Ole Maaløes Vej 3, 2200 København N

Other companies at the same address

Similar companies in København

Questions and answers about Xendara Bio ApS

Has Xendara Bio ApS gone bankrupt?

No, Xendara Bio ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Xendara Bio ApS?

Our model estimates a bankruptcy risk of 1.6% over the next 12 months (medium risk), which is 1.1 times the average for Danish companies.

Who is the CEO of Xendara Bio ApS?

Kåre Engkilde is the CEO of Xendara Bio ApS.

Who is the auditor of Xendara Bio ApS?

Xendara Bio ApS most recently used AIDER Godkendt Revisionsaktieselskab.

When was Xendara Bio ApS founded?

Xendara Bio ApS was founded on 30 June 2026.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.